Vancouver General Hospital is a medical facility located in Vancouver, British Columbia. It is the largest facility in the Vancouver Hospital and Health Sciences Centre group of medical facilities. VGH is Canada's third largest hospital by bed count, after Hamilton General Hospital, and Foothills Medical Centre.

During the past decade, Vancouver General Hospital conducted 204 clinical trials. In the 10-year time frame, 204 clinical trials started and 56 clinical trials were completed, i.e. on average, 27.5% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 38 clinical trials were completed. i.e. 51.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vancouver General Hospital" #1 sponsor was "University of British Columbia" with 110 trials, followed by "Cardiology Research UBC" with 12 trials sponsored, "McMaster University" with 12 trials sponsored, "Ottawa Hospital Research Institute" with 11 trials sponsored and "Celgene" with 11 trials sponsored. Other sponsors include 214 different institutions and companies that sponsored additional 132 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vancouver General Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 42 trials as a collaborator, "University of British Columbia" with 13 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 11 trials as a collaborator, "Vancouver General Hospital" with 8 trials as a collaborator and "Canadian Critical Care Trials Group" with 6 trials as a collaborator. Other collaborators include 287 different institutions and companies that were collaborators in the rest 198 trials.

According to Clinical.Site data, the most researched conditions in "Vancouver General Hospital" are "Atrial Fibrillation" (17 trials), "Myocardial Infarction" (14 trials), "Coronary Artery Disease" (13 trials), "Heart Failure" (10 trials) and "Stroke" (10 trials). Many other conditions were trialed in "Vancouver General Hospital" in a lesser frequency.

Most popular intervention types in "Vancouver General Hospital" are "Drug" (162 trials), "Device" (61 trials), "Other" (56 trials), "Procedure" (49 trials) and "Biological" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Dexamethasone" (8 trials), "placebo" (6 trials), "Bortezomib" (5 trials) and "Cyclophosphamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Vancouver General Hospital" are 357 trials for "All" genders, 10 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 111 active trials in "Vancouver General Hospital". 3 are not yet recruiting, 65 are recruiting, 41 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 156 completed trials in Vancouver General Hospital, 3 suspended trials, and 46 terminated clinical trials to date.

Out of the total trials that were conducted in Vancouver General Hospital, 19 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 100 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 126 trials that are defined as “Not Applicable".